Related Experiment Video

Updated: May 11, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Chlamydophila pneumoniae infection and cardiovascular disease

Rajnish Joshi1, Bidita Khandelwal, Deepti Joshi

  • 1Department of Medicine, Sikkim Manipal Institute of Medical Sciences, Gangtok, India.

North American Journal of Medical Sciences
|April 30, 2013
PubMed

Insights

Chlamydophila pneumoniae infection was investigated as a cause of atherosclerosis. Despite early promising research, clinical trials showed no benefit from antibiotic treatment, impacting overall research interest in this Chlamydia-atherosclerosis link.

Area of Science:

  • Cardiovascular Science
  • Infectious Disease Epidemiology

Background:

  • Atherosclerosis is a complex inflammatory vascular disease with an unclear inciting cause.
  • Chlamydophila pneumoniae (formerly Chlamydia pneumoniae) infection was proposed as a potential etiological agent for atherosclerosis.
  • Research interest in the Chlamydia-atherosclerosis link has evolved over two decades.

Purpose of the Study:

  • To review published studies on Chlamydophila pneumoniae and its role in atherogenesis.
  • To analyze research trends and interest in the Chlamydia-atherosclerosis topic.
  • To assess the impact of clinical trial outcomes on research focus.

Main Methods:

  • Conducted a PubMed search using "Chlamydia" and "atherosclerosis" keywords.
  • Analyzed 1,652 published articles from 1991 to 2011.
  • Reviewed serological, molecular, animal modeling studies, and antibiotic clinical trials.

Main Results:

  • Early studies showed promising serological, molecular, and animal model evidence for C. pneumoniae in atherogenesis.
  • Over a dozen antibiotic clinical trials targeting C. pneumoniae found no clinical benefits.
  • Negative clinical trial results significantly impacted overall research interest.

Conclusions:

  • While some researchers maintain the importance of C. pneumoniae in atherosclerosis, negative clinical trials have diminished research momentum.
  • Novel mechanisms of atherogenesis necessitate new research paradigms for Chlamydophila-atherosclerosis studies.
  • The role of Chlamydophila pneumoniae in atherosclerosis requires re-evaluation in light of current evidence.

Keywords:
AtherosclerosisCardiovascular diseaseChlamydophila pneumoniaInfection

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: